Why is Godavari Drugs falling/rising?

As of 03-Jul, Godavari Drugs Ltd's stock price is currently at Rs 91.00, reflecting an increase of Rs 1.33 or 1.48%. The stock has shown a trend reversal, gaining after two consecutive days of decline, and it outperformed its sector by 1%. Despite this positive movement today, the stock has underperformed over the past week and month, with returns of -2.36% and -7.71%, respectively. Additionally, the stock is trading below its moving averages, indicating a bearish trend. While the company has an attractive valuation with a return on capital employed (ROCE) of 12.3 and is trading at a discount compared to peers, it has also faced significant challenges, including a -22.1% decline in profits over the past year and a high debt to EBITDA ratio of 3.15 times, suggesting weak long-term fundamentals.
Broader market context indicates that while Godavari Drugs has seen a slight uptick today, its overall performance has lagged behind the benchmark Sensex, which has gained 3.10% over the past month. The stock's year-to-date performance is particularly concerning, with a decline of -16.78% compared to the Sensex's increase of 6.53%. This underperformance in both the short and long term, combined with negative financial results and a high debt burden, paints a challenging picture for the stock's future prospects.